Reprise Biomedical, Inc.

CIK 1782236 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Reprise Biomedical, Inc..

Recent SEC filings

FiledFormAccession number
Jul 1, 2026D/A0001782236-26-000002
May 21, 2026D0001782236-26-000001
Jul 11, 2025D0001782236-25-000003
Dec 13, 2023D/A0001782236-23-000004
Nov 2, 2023D0001782236-23-000003
Jan 25, 2023D/A0001782236-23-000002
Jan 3, 2023D0001782236-23-000001
Mar 31, 2021D/A0001362118-21-000002
Nov 25, 2020D0001362118-20-000019
Jul 12, 2019D0001782236-19-000001